HR8651-119

In Committee

Advancing Safe Medications for Moms and Babies Act of 2026

119th Congress Introduced May 4, 2026

Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.

Summary

What This Bill Does

The bill expands a appropriation, compliance mandate, delegation of rulemaking provision: 2, expands a appropriation, reporting req, compliance mandate provision: 3, and expands a appropriation, reporting req, compliance mandate provision: 4. It relies on appropriations, compliance mandates, reporting requirements, and delegation of rulemaking. The main policy areas are Healthcare.

Who Benefits and How

The available clause analysis does not identify a specific beneficiary group.

Who Bears the Burden and How

No clear private burden is identified from the available clause analysis; implementing agencies may still take on administrative work.

Key Provisions

  • Expands a appropriation, compliance mandate, delegation of rulemaking provision: 2.
  • Expands a appropriation, reporting req, compliance mandate provision: 3.
  • Expands a appropriation, reporting req, compliance mandate provision: 4.

Evidence Chain:

This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for primary purpose and policy domains.

At a Glance

What This Bill Does

The bill expands a appropriation, compliance mandate, delegation of rulemaking provision: 2, expands a appropriation, reporting req, compliance mandate provision: 3, and expands a appropriation, reporting req, compliance mandate provision: 4.

Key Policy Areas

Healthcare

Primary Purpose

The bill expands a appropriation, compliance mandate, delegation of rulemaking provision: 2, expands a appropriation, reporting req, compliance mandate provision: 3, and expands a appropriation, reporting req, compliance mandate provision: 4.

Policy Domains

Healthcare

Legislative Progress

In Committee
Introduced Committee Passed
May 4, 2026

Referred to the House Committee on Energy and Commerce.

May 4, 2026

Introduced in House

May 4, 2026

Ms. Castor of Florida (for herself, Mr. Fitzpatrick, and Ms. …

Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →

Bill Structure & Actor Mappings

Who is "The Secretary" in each section?

Domains
Healthcare
Actor Mappings
"the_commission"
→ The commission identified in the operative section
"secretary_of_health_and_human_services"
→ Secretary of Health and Human Services

We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.

Learn more about our methodology